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Genetically engineered mouse models are commonly preferred for studying the human disease due to
genetic and pathophysiological similarities between mice and humans. In particular, Cre-loxP system is
widely used as an integral experimental tool for generating the conditional. This system has enabled
researchers to investigate genes of interest in a tissue/cell (spatial control) and/or time (temporal control)
specific manner. A various tissue-specific Cre-driver mouse lines have been generated to date, and new
Cre lines are still being developed. This review provides a brief overview of Cre-loxP system and a few
commonly used promoters for expression of tissue-specific Cre recombinase. Also, we finally introduce
some available links to the Web sites that provides detailed information about Cre mouse lines including
their characterization.
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Cre-loxP System
Cre (Cre recombinase) is one of the tyrosine site-
specific recombinases (T-SSRs) including flipase (Flp)
and D6 specific recombinase (Dre) [1,2]. it was
discovered as a 38-kDa DNA recombinase produced
from cre (cyclization recombinase) gene of bacteriophage
P1 [3-6]. It recognizes the specific DNA fragment
sequences called loxP (locus of x-over, P1) site and
mediates site-specific deletion of DNA sequences between
two loxP sites [7,8]. The loxP site is a 34 bp sequences
consisting of a two 13 bp inverted and palindromic
repeats and 8 bp core sequences (Figure 1A).
General principle of Cre-loxP system
Cre-loxP system is a widely used powerful technology
for mammalian gene editing. This system has advantages
which is very simple manipulation and do not require
additional factors for efficient recombination [1].
Concerning the mechanism of Cre-loxP system, a single
Cre recombinase recognizes two directly repeated loxP
site, then the Cre excises the loxP flanked (floxed) DNA,
thus creating two types of DNA with circular, excised
and inactivated gene Y (Figure 1A). While the Cre-loxP
system is predominantly used in genetic excision, it also
induces the inversion and translocation of DNA between
two loxP sites depending on the orientation and location
of loxP sites [1,2,9].
To generate the spatiotemporally controlled mutant
mice, two elements are needed in the Cre-loxP system
[10-13]. First, Cre-driver strain is generated in which Cre
recombinase is expressed by a promoter that specifically
targets the cell or tissue of interest. Second, loxP flanked
(floxed) DNA containing mouse strain is needed to be
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generated. Conditional knockout mice are then generated
by breeding the Cre-driver strain with a floxed mouse
strain (Figure 1B). The specificity and timing of
recombination are controlled by used promoter and/or
enhancer.
Inducible Cre-loxP system; CreERT
To achieve more accurate genetic functional studies
and clinical applications using Cre-loxP system, it was
required a more sophisticated technique that controls the
Cre activation at the precise time and in a specific cell.
An inducible Cre system is controlled by cell-specific
regulatory elements (promoters and enhancers) and
temporally inducible way by exogenous inducer such as
tamoxifen (tam) or tetracycline (tet) [1,10,14-17].
Tamoxifen-inducible Cre system is achieved by
modified Cre protein fused with the estrogen receptor
containing a mutated ligand binding domain (ER-LBD)
[14,15]. The fused Cre protein is called CreER
recombinase, tamoxifen (also known as CreERT, Cre-
ERT) and normally presented in the cytoplasm in a form
that binds to heat shock protein 90 (HSP90). Upon
binding the synthetic steroids (such tamoxifen or 4-
hydoxytamoxifen; 4-OHT), the interaction is disrupted
between HSP90 and CreERT. This causes nuclear
translocation of CreERT and the interaction of Cre with
loxP sites (Figure 2A). In this system, tamoxifen is
systemically administered via intraperitoneal injection.
To improve the function of targeted mutagenesis using
CreERT, a new version of CreER, CreERT2 (Cre-ERT2),
that is about ten-folds more sensitive to 4-OHT in vivo
than CreERT has been generated [15,18]. Thus, the use
of CreERT2 is more preferred in several biological
fields.
Another temporal and cell specific inducible system is
tetracycline (Tet) system, also called doxycycline (Dox;
a tetracycline derivative)-inducible Cre system. Dox is
much more cost-effective, usable and efficient in
controlling the Tet receptor (TetR) than tetracycline. This
system is available in two modes, Tet-on and Tet-off,
which permit Dox-dependent gene activation [19,20] or
inactivation [17]. The Tet systems consist of three
elements, reverse tetracycline-controlled transactivator
(rtTA), tetracycline-controlled transactivator (tTA) and
tetracycline responsive element (TRE), also referred to
as a tetracycline operon (TetO), which regulates a cre
gene expression. When the rtTA binds to Dox, it can
bind to the tetO7 (7 repeats of tetO) sequences and
activates Cre gene expression (“Tet-on”) (Figure 2B), on
the other hand, tTA binds to tetO7 sequences in normally,
and when it is coupled with Dox, it can no longer bind
to the tetO7 sequences and inactivates Cre expression
(“Tet-off”) (Figure 2C). In Tet system, doxycycline is
usually administered in feed or drinking water.
Figure 1. Mechanism of Cre-loxP system. (A) An overview of Cre-loxP system. 38 kDa Cre recombinase recognizes the loxP sites
of specific 34 bp DNA sequences. (B) General breeding strategy for conditional mutation using loxP and Cre driving mouse line. In
principle, one mouse must have a tissue-specific driven cre gene and another mouse have loxP flanked (floxed) alleles of interest
gene Y. Expression of Cre recombinase excises floxed loci and inactivates the gene Y.
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Tissue-specific promoters of Cre lines
Due to the usefulness of the Cre-loxP system, numerous
organ-specific Cre and/or inducible Cre transgenic
mouse lines have been created and are still being
developed. Here, we provide some most commonly used
tissue-specific promoter/enhancer of Cre driver lines in
Table 1. The various organs were divided into 6
physiological systems: nervous, integumentary, immune,
musculoskeletal, digestive and urogenital system. The
useful promoters of Cre are selected and summarized
based on International Mouse Phenotyping Consortium
(IMPC), Mouse Genome Informatics (MGI), The
Jackson Laboratory (JAX Cre repository) and National
Center for Biotechnology Information (NCBI) databases.
Figure 2. Principles of Inducible Cre-loxP mutation system. (A) Tamoxifen (Tam)-inducible System of estrogen receptor fused to
Cre (CreER). In the absence of tamoxifen, expressed fusion protein, CreER, interacts with heat shock protein 90 (HSP90) and
exists in cytoplasm (1). Administration of Tam disrupts the interaction of HSP90 with CreER (2). Interaction of ER with Tam induces
nuclear translocation of Cre (3). In the nucleus, the CreER recognizes the loxP sites (4) and inactivates the gene Y in tissue X (5).
(B and C) Doxycycline (Dox)-induced Tetracyclin (Tet)-on and -off systems. (B) In Tet-on system, ubiquitous or tissue-specific
promoter driven rtTA is expressed. In the absence of Dox, inactivated rtTA is unable to bind tetO
7
 (7 repeats of a 19 nuclotide tetO
minimal promoter, also referred to as TRE) sequence of cre gene. Cre is not expressed. Following Dox administration, Dox
interacts with the rtTA and allows to activate. Activated rtTA binds to tetO
7
 promoter of cre and induces the Cre expression. (C) In
Tet-off system, in the absence of Dox, activated tTA is able to bind tetO
7
 (TRE) sequence of cre and induces the Cre expression.
Upon Dox administration, tTA interacted with Dox is inactivated. Inactivated rTA is not able to bind to tetO
7
 promoter and therefore
Cre expression is inhibited.
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Nervous system
Nervous system consists of two main parts, the central
nervous system (CNS), which includes the brain and
spinal cord, and the peripheral nervous system (PNS),
which includes the all nerves of the entire body. Since
the brain is very anatomically and functionally divided,
we will divide it into three arbitrary regions; cerebrum,
cerebellum and brain stem.
Table 1. Summary of the commonly used Cre promoters for
studying specific tissues
System Tissue/Cell
Targeted 
promoter/
enhancer
References
Nervous (CNS)
Cerebrum
Aldh1l1
CaMIIα
Dlx1
Dlx5/6
Gad2
GFAP
Grik4
Lepr
Nes
nNOS
Pdgfrα
PLP1
Pv (Pvalb)
Slc17a6
Sst
Vip
[21]
[24]
[26]
[27-29]
[30]
[22, 23] 
[25]
[34]
[32]
[30]
[33]
[35]
[30]
[31]
[29]
[29]
Cerebellum Pcp2 [36]
Brain stem
Slc6a3 (DAT)
ePet (Fev)
Npy2r
[37]
[38]
[39]
Spinal cord
Cdh3
Htr6
[40]
[40]
Nervous (PNS)
DRG, SCG Avil [41-45]
Integumentary
Skin 
Krt5
Krt10
Krt14
Krt18
[18]
[48]
[47]
[49]
Hair follicles Lgr6 [50]
Immune
Macrophage Lyz2 [54]
Dendritic cells CD11c (Itgax) [55]
Mast cells CMA1 [56]
T-cells
CD2
CD4
CD8a
Foxp3
Lck
OX40
[57]
[58, 59]
[61]
[62]
[63, 64]
[60]
B-cells CD19 [65, 66]
Haematopoietic
tissue
CD45
(Ly5, Ptprc)
Vav
[70]
[67-69]
Musculoskeletal 
Osteochondro
progenitors
Twist2 (Dermo1)
Prrx1 (Prx1)
[71, 72]
[73]
Osteoblasts
BGLAP (OC)
Col1a1
Sp7
(Osterix, Osx1)
[74]
[75]
[76]
Table 1. Continued
System Tissue/Cell
Targeted 
promoter/
enhancer
References
Osteocytes Dmp1 [77]
Osteoclasts Ctsk [75, 78-80]
Chondrocytes
Acan (Agc1)
Col10a1
[81]
[82, 83]
Muscle
ACTA1 (HSA)
Ckmm (Mck)
Myf5
Myh6 (αMHC)
Tagln (SM22α)
[84]
[87]
[85]
[86]
[88]
Digestive
Esophagus ED-L2 [89-91]
Stomach
Atp4b
H+,K+-ATPase 
b-subunit
Tff1
[92]
[93]
[94]
Intestine
Car1
Vil1
[95]
[96]
Salivary gland Ascl3 [97]
Liver Alb [98, 99]
Pancreas
Gcg (Glu)
Ghrl
Ins1 (MIP)
Ins2 (RIP)
Ppy (PP)
Ptf1a
SOX9
[100, 101]
[102]
[103]
[104]
[101]
[105]
[106]
Urogenital
Bladder Upk2 [107]
Kidney
Aqp2
Foxd1
Gdnf
Ggt1
Kap
Nphs2 (Podocin)
[108]
[109]
[110]
[111]
[112]
[113]
Ovary
Gdf9
Zp3
[114]
[114-116]
Testis
Amh
Hspa2
[117]
[118]
*Note. These promoters are just a few representative examples
of various genes in a tissue
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1) Cerebrum-specific promoters
The aldehyde dehydrogenase 1 family, member L1
(Aldh1L1) [21] and glial fibrillary acidic protein (Gfap)
[22,23] are expressed in astrocytes, but the GFAP is also
known to be expressed in adult neural stem cells.
Expression of calcium/calmodulin-dependent protein
kinase II alpha (CaMK2α) [24] and glutamate receptor,
ionotropic, kainate 4 (Grik4) [25] is detected in each
CA1 and CA3 pyramidal neurons of hippocampus.
Distal-less homeobox 1 (Dlx1) [26], distal-less homeobox
5/6 (Dlx5/6) [27-29], glutamic acid decarboxylase 2
(Gad2), synthase 1, neuronal (nNos), parvalbumin (Pv,
also called Pva, Parv) [30], somatostatin (Sst) and
vasoactive intestinal polypeptide (Vip) promoters are
predominantly expressed in inhibitory GABAergic
interneurons [29], whereas the solute carrier family 17;
sodium-dependent inorganic phosphate cotransporter,
member 6 (Slc17a6) is expressed in excitatory glutamatergic,
vesicular glutamate transport 2 (VGLUT2)-positive
neurons [31]. The nestin (Nes) is also expressed in
precursor cells of neuron and glia [32]. Platelet derived
growth factor receptor, alpha polypeptide (Pdgfrα) is
expressed in inner nuclear layer of the retina [33]. This
promoter is useful in studies of retinal degenerative
diseases such as age-related macular degeneration
(AMD) and retinitis pigmentosa (RP). Expression of the
leptin receptor (Lepr) is detected in hypothalamus and
amygdala, and the promoter is used in research related
to food intake and energy expenditure [34]. In the study
of oligodendrocytes, proteolipid protein (myelin) 1
(PLP1) promoter is very useful in the studies of the gene
function in myelination of mature oligodendrocytes [35].
Here, we provide the detailed expression regions of
cerebral specific promoters in Table 2.
2) Cerebellum-specific promoters
In the cerebellum, Purkinje cells are the most salient
cell type and play a major role in the cerebellar circuit.
Purkinje cell protein 2 (Pcp2) is expressed in most
Purkinje cells and is very useful for cerebellar studies
[36].
3) Brainstem and Spinal cord-specific promoters
The brainstem is a region located between cerebrum
and spinal cord and connects the two. Brainstem consists
of three regions: midbrain, pons and medulla oblongata
of the hindbrain. Solute carrier family 6; neurotransmitter
transporter, dopamine, member 3 (Slc6a3 also known as
DAT; dopamine transporter 1) is expressed in dopaminergic
neurons of the midbrain and used for studying drug
addiction and Parkinson’s disease [37]. FEV; ETS
oncogene family (Fev, also known as ePet) is expressed
in the serotonin (5HT)-specific neurons of the midbrain,
especially in the dorsal ad median raphe regions [38].
Neuropeptide Y receptor Y2 (Npy2r) expression is
restricted in subsets of vagal sensory neurons in the lung
Table 2. Expression regions of cerebral specific promoters
Isocortex Olfactory areas Hippocampus Cortical Subplate Striatum Pallidum 
Aldh1L1
CaMK2α
Dlx1
Dlx5/6
Gad2
GFAP
Grik4
Lepr
Nes
nNos
Pdgfrα
PLP1
Pv
Slc17a6
Sst
Vip
*Table 2 is summarized by quoting data from ALLEN BRAIN ATLAS (http://mouse.brain-map.org/). 
*Table 2 is based on the in situ hybridization data of the adult mouse brain (postnatal 56 day).
*Expression levels above the threshold (0.15 of raw expression value) are considered significant value.
*Raw expression values are expressed as arbitrary units with different colors; 
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and brainstem that regulate respiration [39]. In spinal
cord, cadherin 3 (Cdh3) and 5-hydroxytryptamine;
serotonin, receptor 6 (Htr6) are expressed in a subclass
of inhibitory and excitatory interneurons in the dorsal
horn of the spinal cord, respectively and these promoters
have been used in neuronal functional studies [40].
4) PNS-specific promoters
Unlike the identification of enormous amounts of
CNS-specific promoters of Cre, there are not many
useful PNS-specific promoters. Actin-binding protein,
Advillin (Avil)-driven Cre is expressed in all dorsal root
ganglion (DRG) and trigeminal neurons but not in
superior cervical ganglia (SCG) and is widely used for
the studies of nociception in sensory neurons [41-45].
Integumentary system
The integumentary system consists of the skin and its
appendages such as hair, nails, sebaceous glands and
sweat glands. Skin has at least three layers: epidermis
(outer layer), dermis (middle layer) and hypodermis
(deeper fatty layer, known as subcutaneous layer).
1) Skin and hair follicle-specific promoters
Epidermis, the top layer of skin, has five layers:
stratum corneum, stratum lucidum, stratum granulosum,
stratum spinosum and stratum basale. Each layer is
composed of keratinocytes in different states [46].
Keratinocytes is the main cell type (~90%) of the
epidermis and produces keratin, an intermediate filaments
protein. Keratin 5 (Krt5) and Keratin 14 (Krt14) is
expressed in basal keratinocytes of stratum basale
[18,47]. Keratin 10 (Krt10) is expressed in post-mitotic
suprabasal keratinocytes [48]. Keratin 18 (Krt 18)
expression is observed in Merkel cells of the basal
epidermal layer [49]. Leucine-rich repeat-containing G
protein-coupled receptor 6 (Lgr6, also known as GPCR)
is expressed in hair placodes at embryonic stage and in
follicle bulge of dermis at adult stage [50].
Immune system
Immune system is a host defense response against
foreign invaders, and it protects the body from disease.
This system consists of two working modes: innate
immunity (also called non-specific, natural or native
immunity), which is a first defense mechanism against
invaders and initiates the adaptive immunity, and the
adaptive immunity (also called specific or acquired
immunity), which is systemic response mediating by
lymphocytes such as T and B cells [51-53]. The
leukocytes, three major phagocytes (dendritic cells,
macrophages and neutrophils), basophils, eosinophils,
mast cells and natural killer cells (NK cells), are included
in innate immunity and the helper T, cytotoxic T and B
lymphocytes are included in adaptive immunity.
1) Macrophage/Monocyte-specific promoters
Lysozyme 2 (Lyz2) is expressed in various myeloid
cells including monocytes, macrophages and granulocytes.
It is used for the studies of myeloid cell lineage tracing
and the innate immunity [54].
2) Dendritic cells and Mast cells-specific promoter
Dendritic cells and mast cells are involved in innate
immunity. To study the homeostasis and function of
dendritic cells, Integrin alpha X (Itgax, also known as
CD11c) promoter is used [55]. Chymase 1 (CMA1) is
expressed in mast cells of tissues and can be used for the
studying of their function or fate mapping [56].
3) T and B cells-specific promoters
T and B lymphocytes are representative immune cells
involved in adaptive immunity. CD2 molecule (CD2) is
expressed in peripheral T cells such as CD4 and CD8
cells [57]. The CD4 antigen (CD4), a membrane
glycoprotein, is expressed in CD4-expressing T cells in
lymphoid tissues and used for the studies of CD4-
expressing T cell maturation and proliferation [58,59].
Tumor necrosis factor receptor superfamily, member 4
(OX40, also known as ACT35, Txgp1, TXGP1L and
CD134) is also expressed in activated CD4-positive T
cells [60]. Expression of CD8 antigen, alpha chain
(CD8a) is only observed in peripheral CD8-positive T
cells but not CD4-T cells [61]. Forkhead box P3 (Foxp3)
is used for studying the lineage stability of regulatory T
cells (Treg) [62]. Lymphocyte protein tyrosine kinase
(Lck) is mainly expressed in T cells and used for the
selection and maturation studies of T cell development
in thymus [63,64]. CD19 antigen (CD19) is known to B-
lymphocyte surface antigen and is expressed throughout
B-lymphocyte development [65,66]. 
4) Haematopoietic cells-specific promoters
The protein tyrosine phosphatase, receptor type, C
(Ptprc also known as CD45, Ly5) and vav 1 oncogene
(Vav) are useful for studying gene function in
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haematopoietic stem cells (HSCs) [67-70].
Musculoskeletal system
The musculoskeletal system (also known as the
locomoter system) is composed of two systems, muscular
and skeletal system. This organ system is made up of the
bones (the skeleton), muscles, cartilage, tendon, ligaments,
joints and other connective tissues that bind tissues and
organs together.
1) Mesenchymal stem cells/Osteochondro progenitors,
Osteoblasts, Osteocytes and Osteoclasts-specific promoters
The bone formation (also known as ossification) process
is caused by two types of ossification: intramembranous
ossification (including skull and clavicle), bone is
developed directly from mesenchyme or fibrous connective
tissue and endochondral ossification, bone is created
from a pre-existing cartilage. A majority of the skeleton
is formed by endochondral ossification. In the bone
formation, three different types of cells are involved:
Osteoblasts, Osteocytes and Osteoclasts.
The bone cells, Osteoblasts (immature, bone-forming
cells) and Osteocytes (mature bone cells), are derived
from osteochondro progenitor cells arose from mesenchymal
stem cells (MSCs). In studying these cells, two twist
basic helix-loop-helix transcription factor 2 (Twist2 also
known as Dermo1) [71,72] and paired related homeobox1,
rat (Prrx1 also known as Prx1) [73]-containing promoters
are used in osteochondro progenitor cells and mesenchymal
cells. Also, for the bone growth and physiological
studies, bone gamma-carboxyglutamate protein (BGLAP;
OC, also known as HOC, OCN, Osteocalcin) [74],
collagen, type I, alpha 1 (Col1a1) [75] and Sp7 transcription
factor 7 (Sp7, also known as osterix, Osx1) [76] -promoters
are used for osteoblasts and Dmp1 (dentin matrix protein
1) is used for osteocytes [77]. The osteoclasts, which is
the bone-resorbing cells, are derived from hematopoietic
progenitors. For studying the functional regulation of
osteoclasts, cathepsin K (Ctsk) promoter is used [75,78-
80].
2) Chondrocytes-specific promoters
Chondrocytes are located in the lacunae of the
cartilage. Aggrecan (Acan, also called Agc1) [81] and
collagen, type X, alpha 1 (Col10a1) [82,83] promoters
are used for cartilage-related diseases and physiological
studies. Especially, Col10a1 is preferred in hypertrophic
chondrocytes study.
3) Muscle-specific promoters
The muscular system includes three different types of
muscle tissue: skeletal (also called striated), smooth
(non-striated) and cardiac muscles. Actin, alpha 1,
skeletal muscle (ACTA1 also known as HAS) [84]
expressed in striated muscles, myogenic factor 5 (Myf5)
[85] and myogenic factor 6 (Myh6 also known as
αMHC) expressed in differentiated myocytes [86] are
used in studies of skeletal muscle. Creatine kinase,
muscle (Ckmm also known as Mck) is expressed in both
skeletal and cardiac muscles [87]. Transgelin (Tagln also
known as SM22α; smooth muscle protein 22-alpha) is
expressed in vascular smooth muscle cells of liver and
lung and used in studies of vascular diseases [88].
Digestive system
This system includes digestive tract and various
accessory organs to assist digestion by secreting
enzymes. The digestive tract (also called gastrointestinal
tract) consists of the mouth, esophagus, stomach, small
intestine, large intestine and anus. The accessory organs
consist of salivary glands, liver, pancreas and so on.
1) Esophagus, Stomach and Intestine-specific promoters
Expression of the ED-L2 promoter of the Epstein-Barr
virus, (ED-L2) is reported in squamous epithelial of the
tongue, esophagus and forestomach in previous studies
[89-91]. To study the gastric cancer and diseases of the
stomach, the ATPase, H+/K+ exchanging, beta polypeptide
(Atp4b) [92], H+,K+-ATPase b-subunit (HK) [93] and
trefoil factor 1 (Tff1, also known as PS2 or Bcei)
promoters have been used. Atp4b and HK are expressed
in progenitors of parietal cells and parietal cells secreting
hydrochloric acid (HCl) and intrinsic factor, respectively.
Tff1 is expressed in the epithelium of the glandular
stomach, a source of secreting gastric enzymes and acid
for digestion [94].
The carbonic anhydrase 1 (Car1) is expressed in the
large intestinal tissues, including the cecum and colon [95].
This promoter is useful in colon disease research. Villin
1 (Vil1) promoter is most widely used in intestine studies
and is expressed in epithelial cells of the small and large
intestines from embryonic day 12.5 to adulthood [96].
2) Salivary gland, Liver and pancreas-specific promoters
Achaete-scute family bHLH transcription factor 3
(Ascl3 also known as Sgn1) promoter is expressed in
progenitors of both secretory acinar and ductal cells, and
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thus it is used in developmental studies of salivary gland
[97]. Albumin (Alb) promoter is known to exclusively
express the Cre recombinase in the liver and are the most
commonly used in liver-specific genetic studies [98,99].
Pancreatic cells are divided two compartments: alpha,
beta, delta, epsilon and PP (pancreatic polypeptide) cells
are involved in endocrine function and acinal cells and
epithelial cells lining ducts are involved in exocrine
function. So far, various pancreatic cell-specific promoters
have been identified and used. Glucagon (Gcg, also
known as Glu) [100,101], ghrelin (Ghrl) [102] and
pancreatic polypeptide (Ppy, also known as PP) [101] are
used for alpha, epsilon and PP cells, respectively. Insulin
I (Ins1, also known as MIP) [103] and insulin 2 (Ins2,
also known as RIP) [104] are available in beta cell
specific studies. Pancreas specific transcription factor, 1a
(Ptf1a) [105] and SRY (sex determining region Y)-box
9 (SOX9) [106] are useful in pancreatic acinal and ductal
cell studies, respectively.
Urogenital system
The Urogenital system is composed of urinary system
including bladder and kidney and reproductive organs
including ovary and testis.
1) Bladder and Kidney-specific promoters
Uroplakin 2 (Upk2) is expressed in urothelium of the
bladder and used for the bladder cancer and urothelium
functional studies [107]. The promoters for the kidney
study are as follows. Aquaporin 2 (Aqp2) is expressed
in collecting duct of the kidney and used in nephrological
studies [108]. Forkhead box D1 (Foxd1) is detected in
metanephric mesenchyme and is useful in studies of
pericyte differentiation and fibrotic disease of kidney
[109]. The expression of glial cell line derived neurotrophic
factor (Gdnf) is restricted in renal progenitor cells and
this promoter is useful in kidney developmental studies
[110]. Gamma-glutamyltransferase (Ggt1) is expressed
in the cortical tubular epithelium of the kidney and used
for studying polycystic kidney disease and renal fibrosis
[111]. Kidney androgen regulated protein (Kap) is expressed
in renal proximal tubule of male kidney [112]. Nephrosis
2 (Nphs2, also known as podocin) is exclusively expressed
in podocytes within the kidney glomeruli [113].
2) Ovary and Testis-specific promoters
Growth differentiation factor 9 (Gdf9) is expressed in
oocytes of the primordial follicles and used in
folliculogenesis and oocyte developmental studies [114].
Expression of the zona pellucida glycoprotein 3 (Zp3) is
detected in female germ line, and thus this promoter is
useful for generating the deletion of the desired gene in
the germ line [114-116]. Expression of the anti-
Mullerian hormone (Amh) [117] is restricted in Sertoli
cells and used in studies of the male embryonic sexual
differentiation and spermatogenesis. Heat shock protein
2 (Hspa2) is expressed in spermatocytes and spermatids
within the testis and this promoter is useful in assessing
the gene functional studies during and after meiotic
prophase in pachytene spermatocytes [118].
Accessing the useful resources of 
Cre driver lines: Cre portal sites
To date, a huge numerous Cre transgenic mouse lines
have been established and being generated continuously.
Here we introduce a free, publicly accessible web site
that can be used to provide more accurate and versatile
information on the Cre mouse lines required by the
researchers in Table 3.
Unfortunately, there is still no worldwide database site
where researchers can find all the information about the
desired Cre mouse lines in one place. The scientific
community makes a constant effort for efficiency in
collecting and sharing this information. Coordination of
resources for conditional expression of mutated mouse
alleles (CREATE) consortium web site (http://creline.
org/) had integrated and provided information on Cre
mouse lines from four international partner databases:
Cre portal at MGI (http://www.creportal.org), Cre-X-
Mice (http://nagy.mshri.on.ca/cre_new/index.php), CreZoo
(http://bioit.fleming.gr/crezoo) and CreERT2Zoo (http://
www.ics-mci.fr/crezoo.html) [119-126]. But now information
of CREATE has integrated into Cre portal at International
Mouse Phenotyping Consortium (IMPC) (https://www.
mousephenotype.org/data/order/creline). Cre portal sites
of MGI and CreZOO are available, but Cre-X-Mice and
CreERT2Zoo has integrated into Mouse Resource
Browse (MRB) (http://bioit.fleming.gr/mrb) and MouseCre
(Mouse Cre and CreERT2 zoo) (http://mousecre.
phenomin.fr/), respectively. The Jackson Laboratory’s
Cre Repository (http://www.Jax.org/research-and-faculty/
resources/cre-repository), Neuroscience Blueprint Cre
Driver Network of NIH (National Institutes of Health)
(http://www. credrivermice.org/) and Gene Expression
Nervous System Atlas (GENSAT) (http://www.gensat.
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org/cre,jsp) can also be used to find information about
desired Cre mouse lines. In particular, GENSAT [21,
127] and Neuroscience Blueprint Cre Driver Network
[29] provide useful information in neuroscience.
Conclusions
Technology using Cre-loxp system provides the
sophistication to study the gene functions. To date, a
tremendous amount of Cre-driver lines has been developed
by researchers and are being shared through international
networks. Recently, Cre-loxp system for more precise
control has been continuously developed. Various types
of Cre plasmids are being developed such as fluorescent
Cre fused to fluorescent reporter, optimized Cre with
high expression ratio and split Cre having the different
promoters in N- and C-terminal regions. In addition,
Cre-loxp system approaches has been continually being
developed using Crispr/Cas9 technology and viral
system. Using more sophisticated control techniques,
researchers will be able to understand more precise gene
functions by studying the function of specific genes at
desired time (temporal) and tissue (spatial). The useful
Cre-related portal sites and databases will enhance the
efficiency of research by allowing researchers to find
and obtain the suitable Cre-driver lines for research.
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